Amarin to Report First Quarter 2022 Financial Results and Host Conference Call On May 4, 2022
Amarin Corporation plc (NASDAQ:AMRN) will host a conference call on May 4, 2022, at 8:00 a.m. ET, to discuss its first quarter 2022 financial results.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Amarin Corporation plc (NASDAQ:AMRN) will host a conference call on May 4, 2022, at 8:00 a.m. ET, to discuss its first quarter 2022 financial results. This call follows the anticipated release of the financial results earlier that day. Investors can access the live call via the investor relations section of Amarin's website or by dialing in. The company is focused on advancing cardiovascular disease management and has a global presence with offices in multiple countries.
Positive
- Anticipated release of Q1 2022 financial results could indicate potential growth or positive developments.
Negative
- None.
Details
News Market Reaction – AMRN
The recorded move for AMRN in the trading session of this news was +1.92%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
DUBLIN, Ireland and BRIDGEWATER, N.J., April 19, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with members of Amarin’s senior management team to discuss the Company's first quarter 2022 financial results on Wednesday, May 4, 2022 at 8:00 a.m. ET. The conference call will follow the anticipated release of the Company's financial results earlier that day.
Conference Call and Webcast Information:
Access to live call:
Go to the investor relations section of the Company's website at www.amarincorp.com
Dial in within the United States: 888-506-0062
International dial in: 973-528-0011
Access Code: 930259
Access to replay:
Dial in within the United States: 877-481-4010
International dial in: 919-882-2331
Access Code: 45008
The replay of the call will also be available through the Company's website shortly after the call and be made available for a period of two weeks.
About Amarin
Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. From our scientific research foundation to our focus on clinical trials, and now our global commercial expansion, we are evolving and growing rapidly. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin, in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world. We are committed to rethinking cardiovascular risk through the advancement of scientific understanding of the impact on society of significant residual risk that exists beyond traditional therapies, such as statins for cholesterol management.
Amarin Contact Information
Investor Inquiries:
Lisa DeFrancesco
Investor Relations Amarin Corporation plc
investor.relations@amarincorp.com (investor inquiries)
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.